Geneva, Switzerland

Amal Therapeutics Sa


USPTO Granted Patents = 6


Forward Citations = 5

Loading Chart...
Loading Chart...

2 inventors (with patents filed for the assignee):

goldMedal Elodie Belnoue (6 out of 6 patents)

silverMedal Madiha Derouazi (6 out of 8 patents)


6 patents:

Company Overview
Amal Therapeutics SA is a biopharmaceutical company based in Switzerland, specializing in the development of innovative cancer immunotherapies. The company focuses on the design and development of therapeutic vaccines that harness the body's immune response to fight cancer. Their lead product candidate, a therapeutic vaccine targeting colorectal cancer, exemplifies their commitment to advancing treatment options for patients. With a strong emphasis on research and development, Amal Therapeutics leverages cutting-edge technology and scientific expertise to create effective immunotherapy solutions. The company's goal is to provide novel treatments that improve patient outcomes and quality of life while addressing the significant unmet medical needs in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#60 in Geneva

#1,587 in Switzerland

Geneva, CH
Geneva, Switzerland
Forward Citations = 5

2 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amal Therapeutics Sa. Retrieved from https://idiyas.com/company/amal-therapeutics-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…